Recce wins safety board approval to dose 4g in R327 UTI infusion trial
Recce Pharma (ASX:RCE) will dose patients with 4g of its R327 intravenous…
Recce Pharmaceuticals Ltd (ASX:RCE)
About Recce Pharmaceuticals Ltd
Key Information
RCE In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 26/04/2024 | Price Sensitive PS Safety Committee Approves High Dose of 4,000mg | 263.52KB | 2.2K |
| 22/04/2024 | Price Sensitive PS Quarterly Activities/Appendix 4C Cash Flow Report | 575.83KB | 1.8K |
| 16/04/2024 | Cleansing Statement | 193.34KB | 259 |
| 16/04/2024 | Application for quotation of securities - RCE | 16.67KB | 830 |
| 16/04/2024 | Price Sensitive PS Recce Completes 5,000 R327 Doses Per Week under GMP | 217.27KB | 14K |
| 08/04/2024 | Price Sensitive PS Recce Pharmaceuticals - Business Update | 582.67KB | 7.5K |
| 03/04/2024 | Price Sensitive PS Patent Granted in Israel for RECCE Anti-Infectives | 324.65KB | 3.0K |
| 21/03/2024 | RECCE Trademark Registered - Canada | 216.83KB | 407 |